Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Novo Nordisk A/S
NOVCurrent price
104.36 EUR
-0.72 EUR (-0.69%)
Last closed
782.9 DKK
Company
www.novonordisk.com
ISIN
DK0062498333
Sector
Healthcare
Industry
Biotechnology
Exchange
XETRA Stock Exchange
Capitalization
3 509 209 006 077 DKK
Yield for 12 month
+22.40 %
1Y
3Y
5Y
10Y
15Y
NOV
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with Aspen Pharmaceuticals to produce insulin products; and with Korro Bio, Inc. for the discovery and development of new genetic medicines to treat cardiometabolic diseases. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark. Address: Novo Alle 1, Bagsvaerd, Denmark, 2880
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
6 543.16 DKKP/E ratio
39.2565Dividend Yield
1.26 %Current Year
+232 260 999 999 DKK
Last Year
+176 954 000 001 DKK
Current Quarter
+68 059 999 999 DKK
Last Quarter
+65 348 999 999 DKK
Current Year
+196 496 000 001 DKK
Last Year
+148 506 000 000 DKK
Current Quarter
+57 786 000 003 DKK
Last Quarter
+55 433 000 001 DKK
Key Figures NOV
1 year
3 years
5 years
10 years
EBITDA
126 561 001 475 DKK
Operating Margin TTM
PE Ratio
39.2565
Return On Assets TTM
22.8 %
PEG Ratio
1.7618
Return On Equity TTM
88.57 %
Wall Street Target Price
6 543.16 DKK
Revenue TTM
258 002 993 152 DKK
Book Value
25.24 DKK
Revenue Per Share TTM
Dividend Share
9.9 DKK
Quarterly Revenue Growth YOY
25.3 %
Dividend Yield
1.26 %
Gross Profit TTM
148 506 000 000 DKK
Earnings per share
20.04 DKK
Diluted Eps TTM
20.04 DKK
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
3.9 %
Profit Margin
34.84 %
Dividend Analytics NOV
Dividend growth over 5 years
80 %Continuous growth
1 yearPayout Ratio 5 years average
31 %Dividend History NOV
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
9.9
Ex Dividend Date
15.08.2024
Forward Annual Dividend Yield
1.26 %
Last Split Factor
2:1
Payout Ratio
49.3 %
Last Split Date
13.09.2023
Dividend Date
–
Stock Valuation NOV
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
39.2565
Forward PE
28.6533
Enterprise Value Revenue
13.4847
Price Sales TTM
13.6014
Enterprise Value EBITDA
25.9805
Price Book MRQ
30.9689
Financials NOV
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators NOV
For 52 weeks
632.97 DKK
1 029.23 DKK
50 Day MA
883.24 DKK
Shares Short Prior Month
–
200 Day MA
872.22 DKK
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart